Antifibrinolytic therapy in the manageme
β
Dr. Thomas L. Ortel; James J. Onorato; Camille L. Bedrosian; Russel E. Kaufman
π
Article
π
1988
π
John Wiley and Sons
π
English
β 488 KB
The Kasabach Merritt syndrome consists of thrombocytopenla, mlcroangiopathic hemolytic anemia, and a localized consumption coagulopathy that develops within the abnormal vascular channels of a hemangloma. In general, these patients demonstrate only mild ebnormalltles of screening clotting tests, but